Notably, IL-15 can increase the expression of both CD226 and TIGIT by intra-tumoral NK cells (98), and combination therapy of IL-15 and TIGIT blockade increased cytotoxicity of NK cells against melanoma and suppressed lung metastasis in mouse melanoma models. The gene discussed is TIGIT; the disease is melanoma.